Edition:
United Kingdom

Gensight Biologics SA (SIGHT.PA)

SIGHT.PA on Paris Stock Exchange

2.01EUR
23 Apr 2019
Change (% chg)

€0.01 (+0.75%)
Prev Close
€1.99
Open
€2.03
Day's High
€2.07
Day's Low
€1.96
Volume
255,772
Avg. Vol
326,263
52-wk High
€5.28
52-wk Low
€1.34

About

Gensight Biologics SA is a France-based company, which specializes in the clinical-stage biotechnology and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The Company, through I ts integrated development platform, combines a gene therapy-based approach with... (more)

Overall

Beta: --
Market Cap(Mil.): €122.62
Shares Outstanding(Mil.): 24.00
Dividend: --
Yield (%): --

Financials

  SIGHT.PA Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -- -- --
ROI: -- 8.91 13.83
ROE: -- 10.06 15.25

Earnings vs. Estimates